Search the Newsreel

Is StoneX Group (SNEX) Quietly Rewriting Its Core Strategy Through R.J. O’Brien Integration Progress?

StoneX Group recently reported strong Q3 2026 results with significant revenue and net income growth, alongside doubled EPS. The company is advancing its strategic initiatives by expanding its payments reach through a partnership with Shinhan Bank and integrating the R.J. O’Brien acquisition. These efforts …

SNEX Q2 Deep Dive: Revenue Growth Amid Margin Pressures and Integration Efforts

SNEX Q2 Deep Dive: Revenue Growth Amid Margin Pressures and Integration Efforts Financial services network StoneX Group (NASDAQ:SNEX) posted $39.68 billion of revenue in Q2 CY2026, up 15.2% year on year. Its GAAP profit of $1 per share was 8.7% below analysts' consensus estimates. …

BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for BioNexus Gene Lab Corp (BGLC), detailing estimated future EPS and revenue growth. It includes current stock information, such as the market capitalization and recent price movements, along with a list of peer companies for comparison. The content …

BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd

BioNexus Gene Lab has filed an initial beneficial ownership statement (Form 3) indicating that Fidelion Diagnostics Pte. Ltd. beneficially owns 392,329 common shares, classifying it as a greater-than-5% holder. This filing, signed by Ling Xiao, notes the ownership as of November 28, 2025, with …

StoneX Group Q3 Earnings Call Highlights

StoneX Group reported a significant increase in Q3 fiscal 2026 net income and net operating revenue, driven by strong performance in its Commercial and Institutional segments. The company's growth was boosted by global hedging activity and contributions from recent acquisitions, R.J. O'Brien and The …

Fidelion Diagnostics reports 392,329 BioNexus Gene Lab Corp (NASDAQ: BGLC) shares

Fidelion Diagnostics PTE. LTD. has reported direct ownership of 392,329 shares of BioNexus Gene Lab Corp (NASDAQ: BGLC) common stock, identifying itself as a greater than 5% holder. This Form 3 filing is an initial statement of holdings and does not indicate any recent …

StoneX Group (NASDAQ: SNEX) insider plans 52,648-share stock sale under Form 144

StoneX Group (NASDAQ: SNEX) has filed a Form 144 indicating a proposed sale of 52,648 common shares on August 7, 2026, through Merrill Lynch on the NASDAQ. This filing also discloses previous common stock sales by Mark Maurer over the last three months, including …

BioNexus Gene Lab Corp (BGLC) Stock News Today

StoneX Q3 Earnings Call Focuses on RJO Synergies, Prime Growth

StoneX Group Inc. (SNEX) highlighted strong fiscal Q3 2026 earnings, exceeding analyst estimates. The company emphasized the successful integration of R.J. O'Brien, moving from client migration to cost savings and cross-selling, and focused on the significant growth of its Global Prime Services. Management also …

StoneX Group Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:SNEX) 2026-08-07

StoneX Group reported a significant increase in Q3 fiscal 2026 net income and net operating revenue, driven by strong performance in its Commercial and Institutional segments. The company's growth was boosted by global hedging activity and contributions from recent acquisitions, R.J. O'Brien and The …

StoneX Group (SNEX) Stock Price Drop Challenges Powerful Earnings Momentum

StoneX Group (SNEX) director sells 1,575 shares, retains 255,271

StoneX Group Inc. director John Moore Fowler reported selling 1,575 shares of Common Stock at $75.41 per share on August 5, 2026, through a Rule 10b5-1 trading plan. Following this transaction, he directly holds 255,271 shares and indirectly owns 6,750 shares through his spouse. …

StoneX Group Drops 8.3% Amid Sector-Wide Selling

StoneX Group Inc. shares fell 8.3% to $69.70 on Thursday as part of a broad selloff affecting capital markets firms. The decline was steeper than that of peers like Virtu Financial and BGC Group, suggesting potential additional concerns beyond general sector weakness. Investors are …

Euronext announces volumes for July 2026

Euronext Paris SA Euronext announces volumes for July 2026 Amsterdam, Athens, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 6 August 2026– Euronext, the leading European capital market infrastructure, today announced trading volumes for July 2026. Monthly and historical volume tables are available at …

Earnings call transcript: StoneX misses EPS in Q3 2026 as shares drop 9%

StoneX Group (NASDAQ: SNEX) lifts nine‑month profit to $441.2M

StoneX Group (NASDAQ: SNEX) reported significantly increased profits for the nine months ending June 30, 2026, with net income more than doubling to $441.2 million and total revenues rising to $124,983.8 million. The company experienced strong Q3 2026 results, driven by substantial growth in …

StoneX Group Inc. Reports Fiscal 2026 Third Quarter Financial Results

StoneX Group Inc. announced strong year-over-year growth for its fiscal 2026 third quarter, driven by double-digit expansion in its Commercial, Institutional, and Payments segments. CEO Philip Smith highlighted the successful integration of the R.J. O’Brien acquisition, which solidified StoneX's position as the largest non-bank …

SNEX Q3 Earnings Top on Commercial and Institutional Gains, Stock Dips

StoneX Group (SNEX) director amends report on stock grant and tax withholding

StoneX Group director John Moore Fowler received 174 restricted shares and had 197 shares withheld for tax obligations at $77.62 per share. This Form 4/A amendment was filed to correct only the number of shares withheld for taxes related to a restricted stock award …

StoneX Group (NASDAQ:SNEX) Issues Earnings Results

StoneX Commercial segment revenue rises 97% in fiscal Q3

StoneX Group reported strong fiscal Q3 2026 results with net operating revenues increasing 47% year over year to $719.7 million and net income doubling to $127.9 million. The Commercial segment saw a 97% rise in revenue, reaching $452.2 million, and the Institutional segment grew …

StoneX Group Inc. (SNEX) Q3 Earnings and Revenues Surpass Estimates

StoneX Group Inc. (SNEX) reported strong Q3 2026 earnings, with $1 per share surpassing the Zacks Consensus Estimate of $0.76 and revenues of $1.47 billion exceeding expectations by 11.57%. The company has consistently beaten EPS estimates three times in the last four quarters and …

StoneX faces valuation test as earnings loom after 60% rally

StoneX Group Inc. is reporting its fiscal third-quarter earnings after a significant 67% year-to-date rally in its stock, which has led to valuation concerns. Analysts expect robust year-over-year growth but a sharp sequential decline in earnings, prompting questions about the sustainability of its premium …

Precious Metals Weekly Front Desk Presentation 080526: Bank of Korea plans gold buying; Fed speakers this week

This StoneX weekly presentation covers precious metals market developments, including the Bank of Korea's gold buying plans and upcoming statements from Federal Reserve speakers. The report, authored by Rhona O'Connell, Head of Market Analysis, analyzes the economic and political background influencing precious metals, with …

StoneX Group Inc. (SNEX) director receives 116 restricted shares vesting over 3 years

StoneX Group Inc. director Diane L. Cooper was granted 116 restricted shares of common stock on July 31, 2026, as part of the company's Restricted Stock Program. These shares, valued at $0.00 each, will vest in three equal annual installments. This transaction increases her …

StoneX Group (SNEX) Earnings Date and Reports 2026

StoneX Fiscal Q3 Earnings, Revenue Rise

StoneX Group (SNEX) On Q3 Earnings Watch And Shinhan Deal Has Valuation In Focus

StoneX (SNEX) Reports Q2: Everything You Need To Know Ahead Of Earnings

StoneX Group Inc. (SNEX) director awarded 174 restricted shares

StoneX Group Inc. director John Moore Fowler received 174 restricted shares of common stock on July 31, 2026, which will vest in three equal annual installments. On the same date, 230 common shares were withheld at $77.62 each to cover tax obligations on a …

StoneX Group (SNEX) Stock Could Be Overvalued Following A Payments Deal

StoneX Group (SNEX) stock, despite a significant 5-year gain, appears overvalued at its current price of US$76.57, especially after a recent analyst downgrade. While a new cross-border payments partnership with Shinhan Bank could boost long-term earnings, the stock's P/E ratio of 20.4x is higher …

StoneX Set to Report Q3 Earnings: How to Approach SNEX Stock Now?

Price to earnings forward of Onex Corporation – TSE:5987

Enterprise value to revenue forward of Onex Corporation – TSE:5987

BioNexus Gene Lab names CFO Chong Set Fui in initial beneficial ownership filing

BioNexus Gene Lab has filed an initial Form 3 for its CFO, Chong Set Fui, dated June 17, 2025. This news brief was generated by Public Technologies using AI and is for informational purposes only, not financial advice. The original content was published via …

BioNexus Gene Lab (BGLC) CEO files Form 3 showing 0.0000 shares

BioNexus Gene Lab Corp (BGLC) CEO and director Tan Lee Su-Leng filed a Form 3, an initial statement of beneficial ownership of securities, reporting 0.0000 shares held directly. This filing, dated August 15, 2023, indicates no buy or sell transactions. The report clarifies that …